GlassScriptPhysician profile
David L Manzo
NPI 1386648103
$3,038.57
in general payments reported to CMS, 2019-2025
19 companies · $678 in 2025
The $678 reported for 2025 was more than what a typical Ophthalmology provider received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $339 · 2020: $118 · 2021: $306 · 2022: $510 · 2023: $510 · 2024: $578 · 2025: $678.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,766.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,765.65 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $992.87 | 2022-2025 | Hydrus Microstent, Tryptyr, Clareon Panoptix Pro |
| Allergan, INC. | $271.82 | 2019-2022 | |
| Horizon Therapeutics Plc | $213.76 | 2022-2023 | Tepezza |
| Tarsus Pharmaceuticals, INC. | $187.59 | 2024-2025 | Xdemvy |
| Sun Pharmaceutical Industries INC. | $187.38 | 2019-2025 | Cequa |
| Oyster Point Pharma, INC. | $181.93 | 2022-2025 | Tyrvaya, Ryzumvi |
| Amgen INC. | $174.93 | 2024 | Tepezza |
| Dompe US, INC. | $132.66 | 2021-2025 | Oxervate |
| Bausch & Lomb Americas INC. | $128.04 | 2023-2025 | Xiidra, Miebo, Vyzulta |
| Aerie Pharmaceuticals, INC. | $125.00 | 2021 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $119.19 | 2019-2021 | |
| Rxsight INC | $76.10 | 2020-2023 | Rxsight Injector Handpiece, Rxsight Injector Cartridge, Rxsight Light Adjustable Lens (Rxlal) |
| Kala Pharmaceuticals, INC. | $75.55 | 2021 | |
| Shire North American Group INC | $68.31 | 2019 | |
| Lombart Brothers, INC. | $30.65 | 2022 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Johnson & Johnson Vision Care, INC. | $24.78 | 2020 | |
| Carl Zeiss Meditec Ag | $19.40 | 2020 | |
| Carl Zeiss Meditec USA, INC. | $18.88 | 2021 | |
| Tearlab Corp | $9.73 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Manzo listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.